Free Content The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease

Authors: Patterson, Dean; Kloner, Robert1; Effron, Mark2; Emmick, Jeffrey2; Bedding, Alun3; Warner, Margaret2; Mitchell, Malcolm3; Braat, Simon4; MacDonald, Thomas5

Source: British Journal of Clinical Pharmacology, Volume 60, Number 5, November 2005 , pp. 459-468(10)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective

To investigate the effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease (CAD). Background

CAD and erectile dysfunction (ED) share similar risk factors. It is important to know the cardiovascular effects of tadalafil in patients with CAD during physical exertion that is comparable with sexual activity. Methods

A randomized, placebo-controlled, double-blind, two-period, crossover study comparing the effects of tadalafil 10 mg and placebo on the time to exercise treadmill test (ETT)-induced myocardial ischaemia in subjects with stable CAD (n = 23; age range: 53–75 years, all exhibited ST-segment depression >1.5 mm at screening ETT at > 5METS). Haemodynamic responses to sublingual nitroglycerin (NTG) were assessed before and after ETT. Results

Compared with placebo, tadalafil did not significantly affect the time to ETT-induced ischaemia (13 min/31 s vs. 13 min/36 s, respectively). Before exercise, NTG evoked decreases in sitting systolic blood pressure (SBP) that were significantly greater when subjects received tadalafil compared with placebo, and after exercise, more subjects experienced a decrease in SBP <85 mmHg in response to NTG after taking tadalafil vs. placebo. When subjects received tadalafil compared with placebo, SBP was lower at rest (-7 mmHg; -12,-2), during ETT (-10 mmHg; -16, -3), and after ETT (-13 mmHg; -19, -7). Conclusion

Tadalafil did not significantly alter the time to ETT-induced ischaemia compared with placebo in subjects with CAD. Tadalafil reduced resting and exercise SBP. Due  to the potential for hypotension, the concomitant use of nitrates and tadalafil is contraindicated.

Keywords: phosphodiesterase 5 inhibitors; nitrate; exercise induced ischaemia; tadalafil

Document Type: Research article

DOI: 10.1111/j.1365-2125.2005.02479.x

Affiliations: 1: The Heart Institute, Keck School of Medicine, University of Southern California Good Samaritan Hospital, Cardiovascular Division, Los Angeles, USA 2: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA 3: Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK 4: Academic Hospital, Department of Cardiology, Maastricht, Netherlands 5: Hypertension Research Centre, Department of Medicine and Therapeutics, Dundee University, Dundee, UK

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A